JD Health International, Inc. Financials

Market Capitalization €19.81 Billion as of Jan. 1, 2026

Valuations Metrics as of Jan. 3, 2026

Trailing PE	33.61
Forward PE
Price to Sales TTM	€0.30
Price to Book MRQ	€2.71
Enterprise to Revenue	-0.46
Enterprise to EBITDA	-12.27

Financial Reports as of Jun. 30, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-06-30
Profit Margin	7.25%
Operating Margin	6.03%
Return on Assets TTM	1.93%
Return on Equity TTM	8.56%

Income Statement

Revenue TTM	€7,946,834,094
Revenue per Share TTM	€20.65
Quarterly Revenue Growth	24.50%
Gross Profit TTM	€1,891,997,400
EBITDA	€651,241,121
Net Income to Common TTM	€576,258,313
Diluted EPS TTM	€0.18
Quarterly Earnings Growth YoY	27.50%

Balance Sheet

Total Cash MRQ	€6,018,273,033
Total Cash per Share MRQ	€15.60
Total Debt MRQ	€
Total Debt to Equity MRQ	0.74
Current Ratio MRQ	2.93
Book Value per Share MRQ	€2.23

Cash Flow

Operating Cash Flow TTM	€1,018,826,734
Levered Free Cash Flow TTM	€705,250,602

8ZN Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding	3,200,115,111
Float Shares	1,017,633,344
Avg 10 Volume	4,142
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	67.97%
% Held by Institutions	16.85%

Stock Price Summary

Beta	1.16
Fifty Two Week Low	€3.22
Fifty Two Week High	€7.70
Fifty Two Week Change	44.26%
Day 50 MA	€6.66
Day 200 MA	€5.68

Dividends and Splits

Forward Annual Dividend Rate	€
Forward Annual Dividend Yield	%
Trailing Annual Dividend Rate	€0.00
Trailing Annual Dividend Yield	0.00%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date